1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. Middle East & Africa Cell and Gene Therapy Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Middle East & Africa Cell and Gene Therapy Market - Key Market Dynamics

5.1 Cell and Gene Therapy Market - Key Market Dynamics

5.2 Market Drivers

5.2.1 Increase in Number of Approval of Cell and Gene Therapies

5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing

5.3 Market Restraints

5.3.1 High Cost of Cell and Gene Therapy Manufacturing

5.4 Market Opportunities

5.4.1 Strategic Initiatives by Companies

5.5 Future Trends

5.5.1 Automation of Cell and Gene Therapy Manufacturing Services

5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market -Middle East & Africa Market Analysis

6.1 Overview Middle East and Africa Cell and Gene Therapy Market Overview

6.2 Middle East & Africa Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031

6.3 Cell and Gene Therapy Market Forecast Analysis

7. Middle East & Africa Cell and Gene Therapy Market Analysis - by Type

7.1 Cell Therapy

7.1.1 Overview

7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

7.2 Gene Therapy

7.2.1 Overview

7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Cell and Gene Therapy Market Analysis - by Services

8.1 Process Development

8.1.1 Overview

8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8.2 cGMP Manufacturing

8.2.1 Overview

8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Regulatory Services

8.3.1 Overview

8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8.4 Bioassay Services

8.4.1 Overview

8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Middle East & Africa Cell and Gene Therapy Market Analysis - by Scale

9.1 Pre-Commercial/R&D Manufacturing

9.1.1 Overview

9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Commercial Scale Manufacturing

9.2.1 Overview

9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Middle East & Africa Cell and Gene Therapy Market Analysis - by Service Providers

10.1 CDMOs

10.1.1 Overview

10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10.2 CMOs

10.2.1 Overview

10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Middle East & Africa Cell and Gene Therapy Market Analysis - by End User

11.1 Contract Research Organizations

11.1.1 Overview

11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11.2 Pharmaceutical and Biopharmaceutical Companies

11.2.1 Overview

11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Academic and Research Institutes

11.3.1 Overview

11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Middle East & Africa Cell and Gene Therapy Market - Country Analysis

12.1 Middle East and Africa Cell and Gene Therapy Market, by Key Country - Revenue (2023) (US$ Million)

12.1.1 Middle East and Africa Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country

12.1.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country

12.1.1.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type

12.1.1.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy

12.1.1.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy

12.1.1.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services

12.1.1.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale

12.1.1.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers

12.1.1.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User

12.1.1.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type

12.1.1.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy

12.1.1.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy

12.1.1.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services

12.1.1.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale

12.1.1.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers

12.1.1.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User

12.1.1.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type

12.1.1.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy

12.1.1.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy

12.1.1.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services

12.1.1.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale

12.1.1.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers

12.1.1.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User

12.1.1.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type

12.1.1.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy

12.1.1.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy

12.1.1.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services

12.1.1.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale

12.1.1.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers

12.1.1.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in Cell and Gene Therapy Market

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Merck KGaA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Charles River Laboratories International Inc

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Lonza Group AG

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 WuXi AppTec Co Ltd

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Takara Bio Inc

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 FUJIFILM Holdings Corp

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 F. Hoffmann-La Roche Ltd

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Catalent Inc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Lotte Corp

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

List of Tables

Table 1. Cell and Gene Therapy Market Segmentation

Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type

Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy

Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy

Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services

Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale

Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers

Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 10. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country

Table 11. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type

Table 12. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy

Table 13. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy

Table 14. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services

Table 15. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale

Table 16. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers

Table 17. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User

Table 18. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type

Table 19. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy

Table 20. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy

Table 21. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services

Table 22. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale

Table 23. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers

Table 24. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User

Table 25. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type

Table 26. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy

Table 27. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy

Table 28. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services

Table 29. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale

Table 30. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers

Table 31. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User

Table 32. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type

Table 33. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy

Table 34. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy

Table 35. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services

Table 36. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale

Table 37. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers

Table 38. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User

Table 39. Recent Organic Growth Strategies in Cell and Gene Therapy Market

Table 40. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market

Table 41. Glossary of Terms

List of Figures

Figure 1. Cell and Gene Therapy Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031

Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)

Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)

Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)

Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)

Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)

Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Middle East and Africa Cell and Gene Therapy Market, by Key Country- Revenue (2023) (US$ Million)

Figure 24. Middle East and Africa Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 25. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)

Figure 26. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)

Figure 27. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)

Figure 28. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)

Figure 29. Growth Strategies in Cell and Gene Therapy Market